iRhythm Technologies, Inc. (IRTC) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Joanne Wuensch
Citigroup Inc., Research Division

Good afternoon, everybody, and thank you for joining us for the post-lunch first meeting. I’m still Joanne Wuensch, the medical technology analyst here at Citibank and thrilled to have the management of iRhythm with us, including Dan Wilson. And we — I was just trying to figure out when you became the CFO?

Daniel Wilson
CFO & Principal Financial Officer

About 14 months ago. September 24. Yes.

Joanne Wuensch
Citigroup Inc., Research Division

It is so fresh. Am I allowed to ask you about that? Or that’s a…

Daniel Wilson
CFO & Principal Financial Officer

Yes. Absolutely.

Joanne Wuensch
Citigroup Inc., Research Division

What are you finding now that you’ve moved from IR to the CFO role?

Daniel Wilson
CFO & Principal Financial Officer

Yes, it’s been a fantastic transition. Obviously, been with iRhythm for 6 years now, have always been incredibly bullish on the company and the opportunities we have in front of us. It’s been really a lot of fun to be in the CFO role and kind of drive where we’re allocating our capital and the initiatives that we’re going after and really driving profitable growth, which iRhythm has been a growth company since its beginning. We’re now, I like to say, a profitable growth company, which I think is important place to be and have a great team supporting me and the rest of the company, including Lisa here. It’s been great.